Welcome to the AGA Self-Assessment Module (SAM) on Gastrointestinal and Hepatic Clinical Pharmacology! Originally authored in 2015, the content was reviewed in April 2020 and updated to match current scientific knowledge.
We’re excited to re-offer this very popular learning module for your use in studying and staying current. We believe SAMs represents a unique contribution to your continuing medical education.
As the title suggests, the questions were written from learning objectives which focused on the medications we use in gastroenterology and hepatology, rather than on the diseases. This module should serve all learners as a useful exercise for identifying any current knowledge gaps, and providing the resources for self-directed learning. The module questions were written in a boards-style format, with a high level of review for content and function. The module questions also serve to provide excellent practice for your board exam review in a focused area of gastroenterology and internal medicine.
Sign in to access [Member Only]
After you sign in, please click the "Launch" button on the top of this page to access the course.
Learning objectives
- Treat a patient taking methotrexate with the appropriate vitamin supplement.
- Understand that gastrointestinal stromal tumors are managed with tyrosine kinase inhibitors directed against the product of a mutated c-kit gene.
- Manage eosinophilic esophagitis.
- Recognize the limited role of alpha-1 antitrypsin infusions in those with alpha-1 antitrypsin-related liver disease.
- Identify the appropriate reversal agent in an over-sedated patient during conscious sedation.
- Recognize magnesium deficiency as a side effect of proton pump inhibitor therapy.
- Identify the mechanisms by which baclofen exerts its therapeutic effect in refractory gastroesophageal reflux disease (GERD) symptoms.
Faculty
Editors:
Arthur J. DeCross MD, AGAF
Amy S. Oxentenko, MD, AGAF, FACP, FACG
Authors:
Kiran Bambha, MD
Lisa M. Gangarosa, MD, AGAF
C. Prakash Gyawali, MD, MRCP, AGAF
Jonathan C. Huang, DO
Sonia S. Yoon, MD
Pricing
| Member | Nonmember |
|---|---|
| $Free |
Not available to nonmembers (member only) |
Accreditation and designation
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC statement
Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MOC/CME expiration date: April 30, 2021
The following disclosures were presented by faculty and staff at the time this SAM was authored.
Kiran Bambha, MD
Disclosed no relevant financial relationships
Arthur J. DeCross, MD, AGAF
Disclosed no relevant financial relationships
Lisa M. Gangarosa, MD, AGAF
Grant/Research Support: Ono Pharmaceuticals, Transtech Pharma
C. Prakash Gyawali, MD, MRCP, AGAF
Advisory Committee: Abbvie
Consulting: Covidien, Abbvie
Grant/Research support: Given Imaging
Speaking and Teaching: Forrest/Ironwood, Abbvie
Jonathan C. Huang, DO
Disclosed no relevant financial relationships
Amy S. Oxentenko, MD, AGAF, FACP, FACG
Disclosed no relevant financial relationships
Brijen J. Shah, MD
Disclosed no relevant financial relationships
Sonia S. Yoon, MD
Disclosed no relevant financial relationships
Michele Young, MD
Disclosed no relevant financial relationships
Planning Committee
Arthur J. DeCross, MD, AGAF
Disclosed no relevant financial relationships
Jane E. Onken, MD, MHS, AGAF
Member: BMS DMC
Major Stock Shareholder: Merck
Suzanne Rose, MD, MSEd, AGAF
Major Stock Shareholder: Abbott Labs, Baxter International, Johnson & Johnson, Novo Nordisk, Perrigo
Advisory Committees or Review Panels: AAMC
AGA Staff
Maura H. Davis
Disclosed no relevant financial relationships
Curricula Resources
APPs, Patient care physicians, Trainees, Training directors/GI division chiefs
Time to Complete: 4.5 hours
Released: May 5, 2020
Expires: April 30, 2021